Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02610699 · ClinicalTrials.gov registry record · NA

Community Pediatric Acceptability Study (CPAS)

A NA study, sponsored by Emory University.

Completed
Registry status
NA
Development phase
75
Enrollment target

NCT02610699 is a NA study that has completed, run by Emory University. The registered enrollment target is 75 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02610699, a NA study, has completed, sponsored by Emory University.

COMPLETED
Registry status
NA
Development phase
75 participants
Enrollment target

Study Summary

Ear infections, or otitis media, are a leading cause of health expenditures and antimicrobial prescriptions in children. Diagnosis of otitis media requires the ability to view the tympanic membrane. An instrument called an otoscope with a light source and a magnifying lens with a plastic tip that conforms to the ear canal is currently the standard of care for examining the tympanic membrane. Interpretation of otoscopic examinations is operator-dependent and cannot be seen by anyone other than the person holding the otoscope. A pocket size attachment that uses the technology and light source of a smartphone to capture images of the ear canal and tympanic membrane facilitates image documentation of the otic examination. In previous studies with the device, the investigators have shown that image quality of photographs of the tympanic membrane taken with the smartphone otoscope are equivalent to those taken with a camera-fitted conventional otoscope. In this study, the Community Provider Assessment Study (CPAS), the investigators will perform a cross-sectional study in which they will randomly assign 3-4 pediatricians to use a smartphone otoscope as the standard of care device for all ear examinations and 3-4 pediatricians to use a conventional otoscope for alternating 1 month periods for 6 months. The parents of children examined during the study period with both devices will be invited to participate in 3 telephone surveys assessing parental satisfaction with the device and antimicrobial use by their child for the otic complaint. The results of this study have the potential to improve diagnosis and management of otitis media, thus improving patient care, reducing costs, and decreasing the opportunity for the development of antimicrobial resistance.

Interventions

  • OTHER Conventional otoscope
  • OTHER Smartphone otoscope

Trial Details

FieldValue
Enrollment Target 75 participants
Start Date 2014-11
Est. Completion 2015-06
Phase NA

Sponsor

Emory University

1,208 total trials

What the Registry Record Tells You About NCT02610699

The ClinicalTrials.gov registry entry for NCT02610699 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 75 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Conventional otoscope is the first listed.

NCT02610699 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02610699 about?

NCT02610699 is a clinical study titled "Community Pediatric Acceptability Study (CPAS)". Ear infections, or otitis media, are a leading cause of health expenditures and antimicrobial prescriptions in children. Diagnosis of otitis media requires the ability to view the tympanic membrane. An instrument called an otoscope with a light source and a magnifying lens with a plastic tip that co...

What is the current status of trial NCT02610699?

This trial is currently completed. It is a NA study. The enrollment target is 75 participants. The study started on 2014-11. Estimated completion is 2015-06.

What interventions are being tested in trial NCT02610699?

The interventions under investigation include: Conventional otoscope (OTHER), Smartphone otoscope (OTHER).

Who is sponsoring clinical trial NCT02610699?

This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.